Safety Study of PF582 Versus Lucentis in Patients With Age Related Macular Degeneration

NCT02121353 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Age Related Macular Degeneration (AMD)

Interventions

DRUG: Lucentis
DRUG: PF582

Sponsor

Pfenex, Inc